UPDATED 20.02.2014 12:54

Organised cervical cancer screening programme in Finland in the invitation year 2003. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 438 municipalities (out of 446).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 174927 1415 0.81 9 0.01 5 0.00 32 0.02 145 0.08 206 0.12 192 0.11 826 0.47
I 162862 3 0.00 - - - - - - - - - - - - 3 0.00
II 10740 208 0.12 - - - - - - 2 0.00 6 0.00 19 0.01 181 0.10
III 1098 1095 0.63 5 0.00 2 0.00 16 0.01 93 0.05 178 0.10 169 0.10 632 0.36
IV 105 105 0.06 3 0.00 3 0.00 15 0.01 49 0.03 22 0.01 4 0.00 9 0.01
V 4 4 0.00 1 0.00 - - 1 0.00 1 0.00 - - - - 1 0.00
Inadequate 118 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 4593 75 1.63 1 0.02 - - 2 0.04 6 0.13 11 0.24 21 0.46 34 0.74
Negative1 4166 4 0.09 1 0.02 - - - - - - - - - - 3 0.07
Positive2 427 71 1.55 - - - - 2 0.04 6 0.13 11 0.24 21 0.46 31 0.67
Total 179520 1490 0.83 10 0.01 5 0.00 34 0.02 151 0.08 217 0.12 213 0.12 860 0.48

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.